Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
Heart (British Cardiac Society)|July 3, 2024
Treatment drop-in in a contemporary cohort used to derive cardiovascular risk prediction equationsJingyuan Liang, Rodney T Jackson, Romana Pylypchuk, et al.
European Journal of Preventive Cardiology|September 28, 2023
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular diseaseAnders Holt, Bruno Batinica, Jingyuan Liang, et al.
Journal of the American Heart Association|June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart DiseaseLars Wallentin, Claes Held, Paul W Armstrong, et al.
American Heart Journal|May 31, 2024
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trialCarla Richardson, Tom Gilbert, Saadia Aslam, et al.
The New Zealand Medical Journal|July 12, 2019
Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29)Andrew Kerr, Mildred Lee, Corina Grey, et al.
Journal of the American Society for Mass Spectrometry|July 15, 2021
Characterization Across a Dispersity: Polymer Mass Spectrometry in the Second DimensionTomos E Morgan, Christopher A Wootton, Bryan Marzullo, et al.
Pageof 21